Literature DB >> 22229841

NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts.

Sanja Coso1, Ian Harrison, Craig B Harrison, Antony Vinh, Christopher G Sobey, Grant R Drummond, Elizabeth D Williams, Stavros Selemidis.   

Abstract

SIGNIFICANCE: Reactive oxygen species (ROS) such as superoxide, hydrogen peroxide, and peroxynitrite are generated ubiquitously by all mammalian cells and have been understood for many decades as inflicting cell damage and as causing cancer by oxidation and nitration of macromolecules, including DNA, RNA, proteins, and lipids. RECENT ADVANCES: A current concept suggests that ROS can also promote cell signaling pathways triggered by growth factors and transcription factors that ultimately regulate cell proliferation, differentiation, and apoptosis, all of which are important hallmarks of tumor cell proliferation and angiogenesis. Moreover, an emerging concept indicates that ROS regulate the functions of immune cells that infiltrate the tumor environment and stimulate angiogenesis, such as macrophages and specific regulatory T cells. CRITICAL ISSUES: In this article, we highlight that the NADPH oxidase family of ROS-generating enzymes are the key sources of ROS and, thus, play an important role in redox signaling within tumor, endothelial, and immune cells thereby promoting tumor angiogenesis. FUTURE DIRECTIONS: Knowledge of these intricate ROS signaling pathways and identification of the culprit NADPH oxidases is likely to reveal novel therapeutic opportunities to prevent angiogenesis that occurs during cancer and which is responsible for the revascularization after current antiangiogenic treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229841     DOI: 10.1089/ars.2011.4489

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  44 in total

Review 1.  Reactive oxygen species: the achilles' heel of cancer cells?

Authors:  Xiaojiang Cui
Journal:  Antioxid Redox Signal       Date:  2012-03-02       Impact factor: 8.401

Review 2.  Redox regulation of vascular remodeling.

Authors:  Keyvan Karimi Galougahi; Euan A Ashley; Ziad A Ali
Journal:  Cell Mol Life Sci       Date:  2015-10-20       Impact factor: 9.261

Review 3.  NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?

Authors:  Joanna Wieczfinska; Milena Sokolowska; Rafal Pawliczak
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 4.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

5.  Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer.

Authors:  Peng Wang; Qiao Shi; Wen-Hong Deng; Jia Yu; Teng Zuo; Fang-Chao Mei; Wei-Xing Wang
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 6.  P21-activated kinase in inflammatory and cardiovascular disease.

Authors:  Domenico M Taglieri; Masuko Ushio-Fukai; Michelle M Monasky
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

Review 7.  Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications.

Authors:  Biagio Ricciuti; Jennifer Foglietta; Rita Chiari; Amirhossein Sahebkar; Maciej Banach; Vanessa Bianconi; Matteo Pirro
Journal:  Med Oncol       Date:  2017-12-04       Impact factor: 3.064

8.  Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases.

Authors:  Jiamo Lu; Prabhakar Risbood; Charles T Kane; Md Tafazzal Hossain; Larry Anderson; Kimberly Hill; Anne Monks; Yongzhong Wu; Smitha Antony; Agnes Juhasz; Han Liu; Guojian Jiang; Erik Harris; Krishnendu Roy; Jennifer L Meitzler; Mariam Konaté; James H Doroshow
Journal:  Biochem Pharmacol       Date:  2017-07-11       Impact factor: 5.858

9.  Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody.

Authors:  Smitha Antony; Yongzhong Wu; Stephen M Hewitt; Miriam R Anver; Donna Butcher; Guojian Jiang; Jennifer L Meitzler; Han Liu; Agnes Juhasz; Jiamo Lu; Krishnendu K Roy; James H Doroshow
Journal:  Free Radic Biol Med       Date:  2013-07-11       Impact factor: 7.376

10.  Combined incubation of colon carcinoma cells with phorbol ester and mitochondrial uncoupling agents results in synergic elevated reactive oxygen species levels and increased γ-glutamyltransferase expression.

Authors:  Seila Pandur; Chandra Ravuri; Ugo Moens; Nils-Erik Huseby
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.